A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma

Lung adenocarcinoma is one of the most malignant diseases worldwide. The immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) and programmed cell death-ligand 1 (PD-L1) have changed the paradigm of lung cancer treatment; however, there are still patients who are resistant. F...

Full description

Bibliographic Details
Main Authors: Yujia Zheng, He Tian, Zheng Zhou, Chu Xiao, Hengchang Liu, Yu Liu, Liyu Wang, Tao Fan, Bo Zheng, Fengwei Tan, Qi Xue, Gengshu Gao, Chunxiang Li, Jie He
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
lung adenocarcinoma
immune infiltration
prognosis
immunotherapy
risk prediction model
signature
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.651406/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2021.651406/full

Similar Items